Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $29.38 ($626K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Open-market sale of $626k HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.97 | 7,273 | $211K | 33.7% |
| 2 | $28.97 | 7,273 | $211K | 33.7% |
| 3 | $29.38 | 3,477 | $102K | 16.3% |
| 4 | $29.38 | 3,477 | $102K | 16.3% |
| Total | $29.10 avg | 21,500 | $626K | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |
| HCAT | SELL | 2021-12-29 | $183K | — | Filing → |